Ms. Yuen has served as one of our directors since June 2021. Ms. Yuen has served as Chief Financial Officer of Penumbra, Inc., a global healthcare company focused on innovative therapies, since December 2019. Penumbra recently announced it has entered into a definitive agreement to be acquired by Boston Scientific. Ms. Yuen is a seasoned executive with more than 25 years of experience within the manufacturing, medical devices and life science industries. Over the course of her career, she has developed financial and operational expertise at both multibillion-dollar public companies and entrepreneurial start-up ventures. Previously, Ms. Yuen served as Vice President of Finance and Divisional Chief Financial Officer for the Genetic Science Division for Thermo Fisher Scientific Inc. and Chief Financial Officer at Mirion Technologies. She has also held leadership roles at Boston Scientific, GLU Mobile, Lifescan Inc., Picker International, Rockwell Automation and Eaton Corporation. Ms. Yuen holds a B.A.Sc. in Accounting, a Master of Accountancy and an M.B.A. from Case Western Reserve University. She qualifies as an audit committee financial expert under SEC rules. Ms. Yuen's significant experience in finance, manufacturing and the medical device industry, along with experience in growing companies, benefit AtriCure's Board and management.